News

(Bloomberg) -- The US coal industry is once again enjoying support from the White House. Yet that’s unlikely to quell the economic challenges that underpin a long-term decline for the dirtiest fossil fuel.Most Read from BloombergAmtrak CEO Departs Amid Threats of a Transit Funding PullbackNew York Subway Ditches MetroCard After 32 Years for Tap-And-GoDespite Cost-Cutting Moves, Trump Plans to Remake DC in His StyleNYC Plans for Flood Protection Without Federal FundsA Malibu Model for Residents o

Bitcoin (CRYPTO: BTC) now trades at about around $82,000, but under the right conditions, it could fly to $200,000 or more, if given enough time. There are a pair of new possibilities in particular that could be responsible for driving a large part of that move. Both of them have to do with the economy and government of China, the world's second-largest economy in terms of gross domestic product (GDP).

Donald Trump has piled pressure on the US Federal Reserve to cut interest rates as he tries to soften the blow from his own tariffs.

Cryptos were supposed to skyrocket in value during a Trump presidency. They still might.

XRP jumped as high as 12% before paring gains, as closely-related Ripple Labs ended its long-standing battle with the U.S. Securities and Exchange Commission (SEC), stating Wednesday that the case had “come to an end.”

The Fed retained forecast for two rate cuts Wednesday, with Powell calling the inflationary impact of Trump's tariffs transitory.

The Fed retained forecast for two rate cuts Wednesday, with Powell calling the inflationary impact of Trump's tariffs transitory.

The Bank of England kept its main U.K. interest rate unchanged at 4.50% on Thursday even though the economy is barely growing and the nation faces more uncertainty in light of the tariff policies being enacted by the Trump administration in the U.S. The decision by the nine-member Monetary Policy Committee was widely expected, and comes a day after the U.S. Federal Reserve also kept interest rates unchanged. Minutes from the meeting showed that eight members voted to keep policy unchanged, with one backing a quarter-point reduction.

HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes. U.S.-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with investor interest also boosting the drugmakers' valuations. Mounjaro, a once-weekly injection approved by India's drug regulator, is priced at 4,375 rupees ($50.67) for a 5 mg vial and 3,500 rupees ($40.54) for a 2.5 mg vial, its lowest doses, the company told Reuters exclusively.

(Bloomberg) -- To the traders who have been piling into the US bond market, the Federal Reserve delivered a message they’d been waiting to hear: US growth will likely slow, any increase in inflation should be brief, and interest rates will probably come down more before the year is out.Most Read from BloombergAmtrak CEO Departs Amid Threats of a Transit Funding PullbackDespite Cost-Cutting Moves, Trump Plans to Remake DC in His StyleNew York Subway Ditches MetroCard After 32 Years for Tap-And-Go